Recruiting
A Phase I/II Trial of ALETA-001 for the Treatment of Participants With B-cell Malignancies
NCT06045910
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +11 more
- Locations
-
- University Hospital Birmingham NHS Foundation Trust Birmingham, United Kingdom
- Cambridge University Hospitals Cambridge, United Kingdom
- St James's University Hospital Leeds, United Kingdom
- University Hospital London Hospital London, United Kingdom